Clinical pharmacokineticsHumansDiabetes MellitusType 2Middle AgedFemale
Exposure-Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Mellitus.
Qinghua Wang, Fan Jiang, Yulong Xu, Yuyang Lei, Li Zhang, Xiaodong Sun
Published: 202510.1007/s40262-025-01570-9
Abstract
BACKGROUND: Efsubaglutide alfa is a novel glucagon-like peptide-1 receptor agonist composed of dual GLP-1 molecules fused with the fragment crystallizable (Fc) region of human immunoglobulin G2. It is designed for the treatment of type 2 diabetes mel…
Preview only. Read the full abstract at the source